MiNK Therapeutics Ownership 2024 | Who Owns MiNK Therapeutics Now?
Institutional Ownership
0.65%
Insider Ownership
74.64%
Retail Ownership
24.71%
Institutional Holders
9.00
MiNK Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 0.68% | - | 234,182 | - | - | 222,286 | Jun 30, 2024 |
| LONGBOW FINANCE SA | 0.48% | 0.02% | 166,666 | - | - | 158,199 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.37% | 0.00% | 127,841 | 22,613 | 21.49% | 121,347 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.28% | - | 96,347 | 7,491 | 8.43% | 91,473 | Jun 30, 2024 |
| BLACKROCK INC. | 0.25% | - | 87,196 | 11,048 | 14.51% | 82,767 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.15% | 0.00% | 50,692 | -188 | -0.37% | 43,000 | Jun 30, 2024 |
| CAPTRUST FINANCIAL ADVISORS | 0.10% | 0.00% | 35,729 | -18,562 | -34.19% | 33,914 | Jun 30, 2024 |
| STATE STREET CORP | 0.07% | - | 25,515 | -82 | -0.32% | 24,219,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.05% | - | 17,561 | 1,929 | 12.34% | 16,669 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.04% | - | 13,121 | -6,976 | -34.71% | 12,454 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.03% | - | 11,073 | -26 | -0.23% | 10,511,000 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.03% | - | 10,860 | -157 | -1.43% | 10,308 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 8,947 | -2,113 | -19.10% | 8,491 | Jun 30, 2024 |
| UBS GROUP AG | 0.01% | - | 3,221 | -11 | -0.34% | 3,057 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.01% | - | 2,038 | -1,099 | -35.03% | 1,934 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.01% | - | 1,941 | - | - | 1,842 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.00% | - | 1,548 | - | - | 1,469 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 1,431 | 511 | 55.54% | 1,356 | Jun 30, 2024 |
| COVESTOR LTD | 0.00% | 0.00% | 1,055 | - | - | 1,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.00% | - | 383 | -217 | -36.17% | 363 | Jun 30, 2024 |
MiNK Therapeutics's largest institutional shareholder is VANGUARD GROUP INC, holding 0.68% of the company's total share outstanding, currently valued at $222.29K. The top 10 institutional shareholders own together 2.47% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LONGBOW FINANCE SA | 0.48% | 0.02% | 166,666 | - | - | 158,199 | Jun 30, 2024 |
| COVESTOR LTD | 0.00% | 0.00% | 1,055 | - | - | 1,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.37% | 0.00% | 127,841 | 22,613 | 21.49% | 121,347 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 8,947 | -2,113 | -19.10% | 8,491 | Jun 30, 2024 |
| CAMELOT PORTFOLIOS, LLC | 0.00% | 0.00% | 205 | 205 | 100.00% | 195 | Jun 30, 2024 |
| CAPTRUST FINANCIAL ADVISORS | 0.10% | 0.00% | 35,729 | -18,562 | -34.19% | 33,914 | Jun 30, 2024 |
| GAME PLAN FINANCIAL ADVISORS, LLC | 0.00% | 0.00% | 170 | - | - | 161 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.15% | 0.00% | 50,692 | -188 | -0.37% | 43,000 | Jun 30, 2024 |
| CHILTON CAPITAL MANAGEMENT LLC | 0.00% | - | 309 | - | - | 294 | Jun 30, 2024 |
| KEY FINANCIAL INC | 0.00% | - | 43 | - | - | 41 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.28% | - | 96,347 | 7,491 | 8.43% | 91,473 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.04% | - | 13,121 | -6,976 | -34.71% | 12,454 | Jun 30, 2024 |
| VANGUARD GROUP INC | 0.68% | - | 234,182 | - | - | 222,286 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 1,431 | 511 | 55.54% | 1,356 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.01% | - | 1,941 | - | - | 1,842 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.05% | - | 17,561 | 1,929 | 12.34% | 16,669 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.03% | - | 10,860 | -157 | -1.43% | 10,308 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | 0.00% | - | 150 | 150 | 100.00% | 143 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.00% | - | 1,548 | - | - | 1,469 | Jun 30, 2024 |
| BLACKROCK INC. | 0.25% | - | 87,196 | 11,048 | 14.51% | 82,767 | Jun 30, 2024 |
The largest MiNK Therapeutics shareholder by % of total assets is LONGBOW FINANCE SA. The company owns 166.67K shares of MiNK Therapeutics (INKT), representing 0.02% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 0.37% | 0.00% | 127,841 | 22,613 | 21.49% | 121,347 | Jun 30, 2024 |
| BLACKROCK INC. | 0.25% | - | 87,196 | 11,048 | 14.51% | 82,767 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.28% | - | 96,347 | 7,491 | 8.43% | 91,473 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.05% | - | 17,561 | 1,929 | 12.34% | 16,669 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 1,431 | 511 | 55.54% | 1,356 | Jun 30, 2024 |
| CAMELOT PORTFOLIOS, LLC | 0.00% | 0.00% | 205 | 205 | 100.00% | 195 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | 0.00% | - | 150 | 150 | 100.00% | 143 | Jun 30, 2024 |
| ASSETMARK, INC | - | - | 1 | 1 | 100.00% | 1 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 107 | - | - | 102 | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | - | - | 2 | - | - | 2 | Jun 30, 2024 |
| HARBOR INVESTMENT ADVISORY, LLC | - | - | 5 | - | - | 5 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.00% | - | 1,548 | - | - | 1,469 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.01% | - | 1,941 | - | - | 1,842 | Jun 30, 2024 |
| VANGUARD GROUP INC | 0.68% | - | 234,182 | - | - | 222,286 | Jun 30, 2024 |
| KEY FINANCIAL INC | 0.00% | - | 43 | - | - | 41 | Jun 30, 2024 |
| CHILTON CAPITAL MANAGEMENT LLC | 0.00% | - | 309 | - | - | 294 | Jun 30, 2024 |
| GAME PLAN FINANCIAL ADVISORS, LLC | 0.00% | 0.00% | 170 | - | - | 161 | Jun 30, 2024 |
| COVESTOR LTD | 0.00% | 0.00% | 1,055 | - | - | 1,000 | Jun 30, 2024 |
| LONGBOW FINANCE SA | 0.48% | 0.02% | 166,666 | - | - | 158,199 | Jun 30, 2024 |
| UBS GROUP AG | 0.01% | - | 3,221 | -11 | -0.34% | 3,057 | Jun 30, 2024 |
As of Jun 30 2024, MiNK Therapeutics's largest institutional buyer is RENAISSANCE TECHNOLOGIES LLC. The company purchased 22.61K stocks of INKT, valued at $121.35K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CAPTRUST FINANCIAL ADVISORS | 0.10% | 0.00% | 35,729 | -18,562 | -34.19% | 33,914 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.04% | - | 13,121 | -6,976 | -34.71% | 12,454 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 8,947 | -2,113 | -19.10% | 8,491 | Jun 30, 2024 |
| ARTAL GROUP S.A. | - | - | - | -1,916 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.01% | - | 2,038 | -1,099 | -35.03% | 1,934 | Jun 30, 2024 |
| MORGAN STANLEY | 0.00% | - | 383 | -217 | -36.17% | 363 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.15% | 0.00% | 50,692 | -188 | -0.37% | 43,000 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.03% | - | 10,860 | -157 | -1.43% | 10,308 | Jun 30, 2024 |
| STATE STREET CORP | 0.07% | - | 25,515 | -82 | -0.32% | 24,219,000 | Jun 30, 2024 |
| SITTNER & NELSON, LLC | - | - | - | -58 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | - | - | - | -48 | -100.00% | - | Jun 30, 2024 |
| LIFESTEPS FINANCIAL, INC. | - | - | - | -28 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.03% | - | 11,073 | -26 | -0.23% | 10,511,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.01% | - | 3,221 | -11 | -0.34% | 3,057 | Jun 30, 2024 |
| LONGBOW FINANCE SA | 0.48% | 0.02% | 166,666 | - | - | 158,199 | Jun 30, 2024 |
| COVESTOR LTD | 0.00% | 0.00% | 1,055 | - | - | 1,000 | Jun 30, 2024 |
| GAME PLAN FINANCIAL ADVISORS, LLC | 0.00% | 0.00% | 170 | - | - | 161 | Jun 30, 2024 |
| CHILTON CAPITAL MANAGEMENT LLC | 0.00% | - | 309 | - | - | 294 | Jun 30, 2024 |
| KEY FINANCIAL INC | 0.00% | - | 43 | - | - | 41 | Jun 30, 2024 |
| VANGUARD GROUP INC | 0.68% | - | 234,182 | - | - | 222,286 | Jun 30, 2024 |
As of Jun 30 2024, MiNK Therapeutics's biggest institutional seller is CAPTRUST FINANCIAL ADVISORS. The company sold -18.56K shares of INKT, valued at $33.91K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CAMELOT PORTFOLIOS, LLC | 0.00% | 0.00% | 205 | 205 | 100.00% | 195 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | 0.00% | - | 150 | 150 | 100.00% | 143 | Jun 30, 2024 |
| ASSETMARK, INC | - | - | 1 | 1 | 100.00% | 1 | Jun 30, 2024 |
MiNK Therapeutics's largest new institutional shareholder by number of shares is CAMELOT PORTFOLIOS, LLC, purchased 205.00 shares, valued at $195.00, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARTAL GROUP S.A. | - | - | - | -1,916 | -100.00% | - | Jun 30, 2024 |
| SITTNER & NELSON, LLC | - | - | - | -58 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | - | - | - | -48 | -100.00% | - | Jun 30, 2024 |
| LIFESTEPS FINANCIAL, INC. | - | - | - | -28 | -100.00% | - | Jun 30, 2024 |
MiNK Therapeutics's largest sold out institutional shareholder by shares sold is ARTAL GROUP S.A., sold -1.92K shares, valued at -, as of undefined.
MiNK Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BRIDGEWAY FUNDS INC | 0.00% | 8,500 | - | - | Mar 28, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 27,384 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 234,182 | -85,953 | -26.85% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 86,646 | -362 | -0.42% | Feb 29, 2024 |
| ETFis Series Trust I | 0.00% | 549 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 3,871 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 32,532 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 2,082 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 2,650 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 150 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 952 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 1,744 | - | - | Jan 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 167 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 194 | - | - | Mar 31, 2024 |
| LAZARD FUNDS INC | 0.00% | 518 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 38,713 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 600 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 926 | - | - | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 747 | - | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 13,954 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 7,940 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 11 | - | - | Dec 31, 2023 |
| RYDEX SERIES FUNDS | 0.00% | 11 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 744 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 58 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 166 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 249 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 448 | - | - | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 11 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 2 | - | - | Dec 31, 2023 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 47 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 509 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 3,100 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 283 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 2,175 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 10,841 | -284 | -2.55% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 11 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 1,075 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 2,228 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 574 | - | - | Mar 31, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 81 | - | - | Dec 31, 2023 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 190 | - | - | Dec 31, 2023 |
MiNK Therapeutics's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 8.50K shares, compromising 0.00% of its total assets.
MiNK Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 9 | -72.73% |
| 31 Mar, 24 | 33 | -8.33% |
| 31 Dec, 23 | 36 | 2.86% |
| 30 Sep, 23 | 35 | -16.67% |
| 30 Jun, 23 | 42 | 281.82% |
| 31 Mar, 23 | 11 | -31.25% |
| 31 Dec, 22 | 16 | 77.78% |
| 30 Sep, 22 | 9 | 28.57% |
| 30 Jun, 22 | 7 | -63.16% |
| 31 Mar, 22 | 19 | -9.52% |
| 31 Dec, 21 | 21 | - |
As of 30 Jun 24, 9 institutions are holding MiNK Therapeutics's shares, representing a decrease of -72.73% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 225,922 | -75.88% |
| 31 Mar, 24 | 936,697 | -5.46% |
| 31 Dec, 23 | 990,803 | 36.95% |
| 30 Sep, 23 | 723,481 | -51.03% |
| 30 Jun, 23 | 1,477,394 | 143.15% |
| 31 Mar, 23 | 607,606 | -6.52% |
| 31 Dec, 22 | 649,999 | 36.67% |
| 30 Sep, 22 | 475,610 | 33.28% |
| 30 Jun, 22 | 356,843 | -54.38% |
| 31 Mar, 22 | 782,155 | -41.52% |
| 31 Dec, 21 | 1,337,515 | - |
MiNK Therapeutics (INKT) has 225.92K shares outstanding as of 30 Jun 24, down -75.88% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 0.65% | 8.77% |
| 31 Mar, 24 | 2.73% | 33.05% |
| 31 Dec, 23 | 2.87% | 64.97% |
| 30 Sep, 23 | 2.10% | 11.11% |
| 30 Jun, 23 | 4.35% | 135.93% |
| 31 Mar, 23 | 1.79% | 28.68% |
| 31 Dec, 22 | 2.50% | 125.82% |
| 30 Sep, 22 | 1.41% | 125.06% |
| 30 Jun, 22 | 1.06% | 19.48% |
| 31 Mar, 22 | 2.33% | 8.84% |
| 31 Dec, 21 | 5.14% | - |
As of 30 Jun 24, MiNK Therapeutics is held by 0.65% institutional shareholders, representing a 8.77% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -57.14% |
| 31 Mar, 24 | 7 | -46.15% |
| 31 Dec, 23 | 13 | 62.50% |
| 30 Sep, 23 | 8 | -80.49% |
| 30 Jun, 23 | 41 | 1266.67% |
| 31 Mar, 23 | 3 | -70.00% |
| 31 Dec, 22 | 10 | 42.86% |
| 30 Sep, 22 | 7 | 250.00% |
| 30 Jun, 22 | 2 | -83.33% |
| 31 Mar, 22 | 12 | -42.86% |
| 31 Dec, 21 | 21 | - |
3 institutional shareholders have increased their position in INKT stock as of 30 Jun 24 compared to 7 in the previous quarter (a -57.14% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | - | -100.00% |
| 31 Mar, 24 | 12 | 20.00% |
| 31 Dec, 23 | 10 | -41.18% |
| 30 Sep, 23 | 17 | 1600.00% |
| 30 Jun, 23 | 1 | -50.00% |
| 31 Mar, 23 | 2 | - |
| 31 Dec, 22 | 2 | - |
| 30 Sep, 22 | - | -100.00% |
| 30 Jun, 22 | 3 | -40.00% |
| 31 Mar, 22 | 5 | - |
| 31 Dec, 21 | - | - |
- institutional shareholders have reduced their position in INKT stock as of 30 Jun 24 compared to 12 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 9 | -72.73% | 225,922 | -75.88% | 0.65% | 8.77% | 3 | -57.14% | - | -100.00% |
| 31 Mar, 24 | 33 | -8.33% | 936,697 | -5.46% | 2.73% | 33.05% | 7 | -46.15% | 12 | 20.00% |
| 31 Dec, 23 | 36 | 2.86% | 990,803 | 36.95% | 2.87% | 64.97% | 13 | 62.50% | 10 | -41.18% |
| 30 Sep, 23 | 35 | -16.67% | 723,481 | -51.03% | 2.10% | 11.11% | 8 | -80.49% | 17 | 1600.00% |
| 30 Jun, 23 | 42 | 281.82% | 1,477,394 | 143.15% | 4.35% | 135.93% | 41 | 1266.67% | 1 | -50.00% |
| 31 Mar, 23 | 11 | -31.25% | 607,606 | -6.52% | 1.79% | 28.68% | 3 | -70.00% | 2 | - |
| 31 Dec, 22 | 16 | 77.78% | 649,999 | 36.67% | 2.50% | 125.82% | 10 | 42.86% | 2 | - |
| 30 Sep, 22 | 9 | 28.57% | 475,610 | 33.28% | 1.41% | 125.06% | 7 | 250.00% | - | -100.00% |
| 30 Jun, 22 | 7 | -63.16% | 356,843 | -54.38% | 1.06% | 19.48% | 2 | -83.33% | 3 | -40.00% |
| 31 Mar, 22 | 19 | -9.52% | 782,155 | -41.52% | 2.33% | 8.84% | 12 | -42.86% | 5 | - |
| 31 Dec, 21 | 21 | - | 1,337,515 | - | 5.14% | - | 21 | - | - | - |
MiNK Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of MiNK Therapeutics's stock was made by Buell Jennifer on Oct 13 2023, selling 695,750 shares at - per share (valued at -). The last insider buy of INKT was made by AGENUS INC on Oct 16 2023, buying 429 shares at $1.10 per share (worth $471.56).
MiNK Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 4 | - | - |
| Q1 2024 | 8 | - | - |
| Q4 2023 | 8 | 4 | 200.00% |
| Q3 2023 | 9 | 2 | 450.00% |
| Q2 2023 | 17 | 3 | 566.67% |
| Q1 2023 | 10 | 1 | 1000.00% |
| Q4 2022 | 5 | - | - |
| Q3 2022 | 6 | - | - |
| Q1 2022 | 9 | - | - |
| Q4 2021 | 1 | 29 | 3.45% |
4 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by MiNK Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 4 | - | - |
| Q3 2023 | 3 | - | - |
| Q2 2023 | 7 | 1 | 700.00% |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | 1 | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 1 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of MiNK Therapeutics's stocks.
MiNK Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| XFOR | X4 Pharmaceuticals, Inc. |
| VECT | VectivBio Holding AG |
| IKNA | Ikena Oncology, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| HOOK | HOOKIPA Pharma Inc. |
| ADAP | Adaptimmune Therapeutics plc |
| SGMO | Sangamo Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| KA | Kineta, Inc. |
| ALVR | AlloVir, Inc. |
| AFMD | Affimed N.V. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| CADL | Candel Therapeutics, Inc. |
| FBRX | Forte Biosciences, Inc. |
INKT Ownership FAQ
Who Owns MiNK Therapeutics?
MiNK Therapeutics is owned by institutional shareholders (0.65%), insiders (74.64%), and public (24.71%). The largest institutional shareholder of MiNK Therapeutics is VANGUARD GROUP INC (0.68% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.00% of total shares).
Who are the major institutional shareholders of MiNK Therapeutics?
MiNK Therapeutics's major institutional shareholders are VANGUARD GROUP INC, LONGBOW FINANCE SA, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, and BLACKROCK INC.. The top five shareholders own together 2.06% of the company's share outstanding.
How many MiNK Therapeutics shareholders are there?
As of Jun 2024, there are 9 institutional shareholders of MiNK Therapeutics.
What percentage of MiNK Therapeutics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 234.18K shares of MiNK Therapeutics, representing 0.68% of the company's total shares outstanding, valued at $222.29K (as of Jun 2024).
What percentage of MiNK Therapeutics is owned by LONGBOW FINANCE SA?
As of Jun 2024, LONGBOW FINANCE SA holds 166.67K shares of MiNK Therapeutics (INKT), compromising 0.48% of the company, valued at $158.2K.
What percentage of MiNK Therapeutics is owned by RENAISSANCE TECHNOLOGIES LLC?
RENAISSANCE TECHNOLOGIES LLC is the third largest holder of MiNK Therapeutics. The company owns 127.84K of the company's shares outstanding (worth $121.35K).